This report contains market size and forecasts of Dolutegravir/Rilpivirine Combination Drug in global, including the following market information:
Global Dolutegravir/Rilpivirine Combination Drug Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Dolutegravir/Rilpivirine Combination Drug Market Sales, 2017-2022, 2023-2028, (K Pcs)
Global top five Dolutegravir/Rilpivirine Combination Drug companies in 2021 (%)
The global Dolutegravir/Rilpivirine Combination Drug market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Self-production API Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Dolutegravir/Rilpivirine Combination Drug include ViiV Healthcare and JNJ etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Dolutegravir/Rilpivirine Combination Drug manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Dolutegravir/Rilpivirine Combination Drug Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Dolutegravir/Rilpivirine Combination Drug Market Segment Percentages, by Type, 2021 (%)
Self-production API
Outsourcing of API
Global Dolutegravir/Rilpivirine Combination Drug Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Dolutegravir/Rilpivirine Combination Drug Market Segment Percentages, by Application, 2021 (%)
Hospital
Clinic
Drug Center
Other
Global Dolutegravir/Rilpivirine Combination Drug Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Dolutegravir/Rilpivirine Combination Drug Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Dolutegravir/Rilpivirine Combination Drug revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Dolutegravir/Rilpivirine Combination Drug revenues share in global market, 2021 (%)
Key companies Dolutegravir/Rilpivirine Combination Drug sales in global market, 2017-2022 (Estimated), (K Pcs)
Key companies Dolutegravir/Rilpivirine Combination Drug sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
ViiV Healthcare
JNJ